The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PACE: A pivotal phase II trial of ponatinib in patients with CML and Ph+ALL resistant or intolerant to dasatinib or nilotinib, or with the T315I mutation.
Jorge E. Cortes
Consultant or Advisory Role - ARIAD (U); Bristol-Myers Squibb (U); ChemGenex (U); Novartis (U); Pfizer (U)
Research Funding - ARIAD; Bristol-Myers Squibb; ChemGenex; Deciphera; Novartis; Pfizer
Dong-Wook Kim
Consultant or Advisory Role - Bristol-Myers Squibb (U); IL-Yang Pharm; Novartis (U); Pfizer (U)
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - Bristol-Myers Squibb; Novartis
Javier Pinilla-Ibarz
Consultant or Advisory Role - ARIAD (U); Bristol-Myers Squibb (U); Novartis (U)
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis
Ronald Paquette
No relevant relationships to disclose
Philipp D. le Coutre
Research Funding - Novartis
Charles Chuah
Honoraria - Bristol-Myers Squibb; Novartis
Franck E. Nicolini
Consultant or Advisory Role - Novartis (U)
Honoraria - ARIAD; Novartis
Research Funding - Novartis
Jane Apperley
Consultant or Advisory Role - ARIAD (U); Bristol-Myers Squibb (U); Novartis (U)
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - Novartis
Hanna Jean Khoury
No relevant relationships to disclose
Moshe Talpaz
Consultant or Advisory Role - ARIAD (U)
John F DiPersio
No relevant relationships to disclose
Daniel J DeAngelo
No relevant relationships to disclose
Delphine Rea
No relevant relationships to disclose
Elisabetta Abruzzese
No relevant relationships to disclose
Martin C Müller
Consultant or Advisory Role - Bristol-Myers Squibb (U); Novartis (U)
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - Novartis
Michele Baccarani
Consultant or Advisory Role - ARIAD (U); Bristol-Myers Squibb (U); Novartis (U); Pfizer (U)
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Novartis
Carlo Gambacorti-Passerini
Consultant or Advisory Role - Bristol-Myers Squibb (U); Novartis (U); Pfizer (U)
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Pfizer
Christopher D. Turner
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Frank G. Haluska
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD (I)
Hagop Kantarjian
Consultant or Advisory Role - ARIAD (U)